Ftse Mib
33.770,05
0,07%
DAX
17.896,50
-0,14%
S&P 500
5.064,20
0,91%
NASDAQ
15.840,96
1,51%
Bitcoin
59.332,57
1,88%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Tarsus Pharmaceuticals Inc (TARS) Tarsus Pharmaceuticals Inc (TARS) Notizie

Tarsus Pharmaceuticals Inc

TARS
34,63
2,14 (6,59%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 22:00:10
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
01/5/202423:00GLOBETarsus to Report First Quarter 2024 Financial Results on..
23/4/202414:30GLOBETarsus Strengthens Financial Position and Refinances..
11/3/202422:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:30GLOBETarsus to Participate at Upcoming Investor Conferences
05/3/202422:09EDGAR2Form 8-K - Current report
05/3/202414:30GLOBETarsus Introduces “Mite Party” Campaign for XDEMVY®..
01/3/202423:26EDGAR2Form 8-K - Current report
01/3/202423:17EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
01/3/202406:07GLOBETarsus Announces Pricing of $100.0 Million Public Offering
29/2/202423:08EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/2/202422:37GLOBETarsus Announces Proposed $100.0 Million Public Offering
29/2/202422:32EDGAR2Form S-3ASR - Automatic shelf registration statement of..
27/2/202422:22EDGAR2Form S-8 - Securities to be offered to employees in employee..
27/2/202422:02EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/2/202412:00GLOBETarsus Reports Strong Fourth Quarter and Full-Year 2023..
22/2/202414:00GLOBETarsus Announces Positive Topline Results from Carpo, a..
20/2/202423:00GLOBETarsus to Report Fourth Quarter and Full Year 2023 Financial..
31/1/202423:00GLOBETarsus to Participate in Fireside Chat at the Sixth Annual..
30/1/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202423:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
18/1/202422:30EDGAR2Form 8-K - Current report
08/1/202415:00EDGAR2Form 8-K - Current report
29/12/202323:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202322:23EDGAR2Form 144 - Report of proposed sale of securities
22/12/202323:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202322:49EDGAR2Form 144 - Report of proposed sale of securities
20/12/202300:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202315:01EDGAR2Form 8-K - Current report
11/12/202314:00GLOBETarsus Announces Positive Topline Results from the Ersa..
01/12/202322:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202322:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/11/202322:35EDGAR2Form 144 - Report of proposed sale of securities
30/11/202322:15EDGAR2Form 144 - Report of proposed sale of securities
22/11/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
17/11/202322:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202322:53EDGAR2Form 144 - Report of proposed sale of securities
09/11/202322:18EDGAR2Form S-3 - Registration statement under Securities Act of..
09/11/202322:05EDGAR2Form 8-K - Current report
09/11/202322:05GLOBETarsus Reports Third Quarter 2023 Financial Results and..
09/11/202322:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202323:35GLOBETarsus to Report Third Quarter 2023 Financial Results on..
20/10/202322:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/10/202322:26EDGAR2Form 144 - Report of proposed sale of securities
22/9/202323:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/9/202322:30EDGAR2Form 144 - Report of proposed sale of securities
06/9/202314:00GLOBETarsus to Ring Nasdaq Stock Market Closing Bell in..
30/8/202322:30GLOBETarsus to Present at Upcoming Investor Conferences
Apertura: 32,31 Min: 32,02 Max: 34,63
Chiusura: 32,49

La tua Cronologia

NASDAQ
TARS
Tarsus Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network